Summit Trail Advisors’s Steris STE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$1.42M Buy
6,411
+1,194
+23% +$292K 0.02% 755
2025
Q4
$1.32M Buy
5,217
+2,031
+64% +$510K 0.02% 657
2025
Q3
$788K Buy
3,186
+2,040
+178% +$488K 0.01% 940
2025
Q2
$275K Sell
1,146
-287
-20% -$66.8K ﹤0.01% 963
2025
Q1
$325K Sell
1,433
-138
-9% -$30.4K 0.01% 312
2024
Q4
$323K Buy
1,571
+698
+80% +$153K 0.01% 278
2024
Q3
$212K Buy
+873
New +$204K 0.01% 660
2018
Q1
Sell
-23
Closed -$2K 1497
2017
Q4
$2K Buy
+23
New +$2.05K ﹤0.01% 1679

Other funds holding STE

Summit Trail Advisors's STE Position: Q1 2026 in Review

Summit Trail Advisors increased its Steris (STE) stake by 23% in Q1 2026, buying an estimated $292K and bringing the position to 6,411 shares worth $1.42M. The position accounts for 0.02% of the portfolio, ranked #755.

Summit Trail Advisors first reported a position in STE in Q4 2017 and has held it in 8 quarters since. 838 funds tracked by Wall St. Rank hold STE as of Q1 2026.

  • Summit Trail Advisors held 6,411 shares of Steris worth $1.42M as of Q1 2026.
  • Summit Trail Advisors bought 1,194 Steris shares in Q1 2026, an estimated $292K.
  • Steris made up 0.02% of Summit Trail Advisors's portfolio in Q1 2026, its #755 holding.
  • Summit Trail Advisors first reported a position in Steris in Q4 2017 and has held it in 8 quarters since.
  • 838 funds tracked by Wall St. Rank held Steris as of Q1 2026.

Based on Summit Trail Advisors's 13F filing for Q1 2026, filed 12 May 2026.